The leading digital media covering global biotech innovation Labiotech.eu is the leading digital media covering the global biotech industry. Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Join them now and enjoy reading our stories! "We are building the Next Generation of Digital Media for Biotech"​ Philip & Joachim, Founders of Labiotech.eu Biotechnology, Life science, News, and Media

Type: Media

The mastermind nexus behind the corporate knowledge and intelligence of the Deep Knowledge Group. DeepTech industry analytics, benchmarking and forecasting renowned for its analytics and strategic consulting services on AI and DeepTech. Its Pharma Division is the leading provider of deep industry intelligence for the AI in Pharma sector. AI, artificial intelligence, big data, DeepTech, FinTech, data science, machine learning, GovTech, InvestTech, Blockchain, drug discovery, pharma, longevity, aging, healthspan, geroscience, agetech, preventive medicine, big data analysis, and data

Type: Startup Activities: it services Technologies: A.I. Data Analytics Blockchain/Cryptocurrency A.I. - Machine Learning

Finding the right clinical trial has never been easier! Klineo is the innovative platform that finally offers an intuitive and intelligent search for clinical trials for patients and doctors in oncology.

Type: Startup Activities: healthtech deeptech Technologies: SaaS

Accelerating CNS Clinical Trials We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience.

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology Data Analytics

Live Locally, Grow Globally A national university located in Osaka, Japan, and founded in 1931, with roots going back as far as 1838 and the establishment of the private "place of learning," Tekijuku, Osaka University is a premier research university not only in Japan but globally as well. With 11 undergraduate schools, 15 graduate schools, two university hospitals, as well as a number of research institutes and joint-use facilities (including the World Premier International Research Center Initiative's Immunology Frontier Research Center) spread over 3 campuses, Osaka University is well-equipped to meet the research needs of the modern era. Osaka University …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

Switzerland's leading startup competition »venture» is an initiative of the ETH Zurich, McKinsey & Company, Switzerland, Knecht Holding, the innovation promotion agency CTI and EPFL Lausanne. As the leading Swiss-wide competition for the best business idea and the best business plan, »venture» supports young entrepreneurs in founding a company. The competition aims to unleash untapped innovation potential by encouraging young entrepreneurs to develop a business idea. A number of renowned companies from Swiss industry and commerce sponsor the competition. Experienced coaches support competition participants in the development of their business idea, the preparation of their business plans, and in the …

Tags: H2020 Type: Incubators & VCs

Wir schaffen Wissen – heute für morgen The Paul Scherrer Institute PSI develops, builds and operates large, complex research facilities and makes them available to the national and international research community. The institute's own key research priorities are in the fields of future technologies, energy and climate, health innovation and fundamentals of nature. PSI is committed to the training of future generations. Therefore, about one quarter of our staff are post-docs, post-graduates or apprentices. Altogether, PSI employs 2200 people, thus being the largest research institute in Switzerland. The annual budget amounts to approximately CHF 400 million. PSI is part of …

Type: Public

Working towards a future where no one dies prematurely from NCDs and all have access to prevention, treatment and care. Access Accelerated is an initiative that brings together leading biopharmaceutical and life science companies committed to tackling the growing burden of non-communicable diseases (NCDs) in low- and middle-income countries. Together with partners from across the global biopharmaceutical sector, multilateral organizations and non-governmental organizations, Access Accelerated works toward a future where no one dies prematurely from treatable, preventable diseases. Launched in 2017, the initiative works to identify and break down barriers to NCD prevention, treatment and care by uniting the efforts …

Type: NGO, Think-tanks, Ed, & Culture Activities: cleantech

We are the leading ecosystem for next generation healthcare – we partner, enable, and connect. Flying Health is the leading ecosystem for next generation healthcare – we partner, enable, and connect. Within our ecosystem, we build bridges between startups, corporates, and relevant stakeholders, transforming industry leaders and entrepreneurs into healthcare pioneers. Our work combines long-standing consulting expertise and innovative trend research that enable closing the gap between healthcare and technological innovation. Together with our partners, we create strategies, business models, and networks that shape the future of healthcare. Digital Health, Incubator, Startups, Internetmedizin, Medical ecosystem, Software as a drug, Digital …

Type: SMB Activities: healthtech entrepreneurship fintech deeptech Technologies: SaaS

London-based venture fund investing in advanced therapies 4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious …

Type: Incubators & VCs

Building tomorrow's antibody-drug conjugates (ADCs) Araris Biotech AG is pioneering a novel linker technology for antibody-drug conjugates (ADCs.) Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering. Antibody Drug Conjugates and ADCs

Type: Startup Activities: biotech deeptech Technologies: SaaS

#empoweringGameChangers redalpine is the Swiss venture capital firm that empowers GameChangers. Founded in 2006, redalpine brings together financial investment, operational expertise, and a vast international network to help ambitious entrepreneurs transform their vision into a reality. With over €1bn in assets under management and a disciplined, sector-agnostic investment strategy, the firm has backed some of Europe’s most disruptive companies, including N26, Taxfix, Inkitt, 9fin, Carvolution, Zenjob, vivenu, and Umiami. redalpine has over 95 companies in its portfolio and invests Europe-wide from its offices in Zurich and Berlin. Venture Capital, Startup Financing, Internet, and Life Science

Type: Incubators & VCs

Pureos is a venture capital fund investing in private innovative drug development companies Pureos Bioventures is a venture capital fund, which invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats. The fund’s portfolio companies are built on scientific excellence to develop therapies across a broad indication spectrum including oncology, immunology, ophthalmology, rare diseases, and neuroscience. Pureos has built a team with deep investment, operating and clinical expertise, that strives to impact patients’ lives by advancing innovative treatments for devastating diseases.

Type: Incubators & VCs